Ivermectin is a prescription antiparasitic medicine that has been used in people since the late 1980s. In the United States, the ivermectin uses that regulators have actually approved are narrow: oral tablets for two specific worm infections, plus topical forms for head lice and for the bumps and pimples of rosacea. It is not approved for viral illnesses, cancer, or general "immune support," and the human dose depends on body weight, which is why ivermectin dosage should always come from a clinician or pharmacist rather than a forum post.

Ivermectin has also become one of the most argued-about drugs in the country. Several states have passed laws since 2025 letting pharmacists sell it without an individual prescription, while the published evidence for its most-discussed off-label use — COVID-19 — has continued to come back negative in large pooled analyses. This guide separates the approved uses from the debated ones, and lists the side effects and interactions reported in the FDA labeling. State-law and availability details below were last verified in late 2026; because bills are still moving, confirm current rules in your own state before assuming anything.

Key takeaways

  • Oral ivermectin is FDA-approved in humans for intestinal strongyloidiasis and for onchocerciasis (river blindness) — not for all parasites, and not for viruses.
  • Topical ivermectin products are approved separately for head lice and for inflammatory lesions of rosacea.
  • Systematic reviews published in 2024 and 2025 found no significant benefit from ivermectin on COVID-19 mortality, ventilation, or hospitalization.
  • Most side effects are mild, but reactions can be more pronounced when the drug kills large numbers of parasites, and rare severe neurologic events have been reported in people co-infected with Loa loa.
  • Ivermectin products sold for horses, cattle, dogs, and other animals are labeled for animal use only and are not approved for people.

What ivermectin is and how it works

A pharmacist's gloved hands counting small white tablets on a stainless steel pill counting tray with a spatula.

Ivermectin belongs to a drug family called the avermectins, derived from a soil bacterium. As the American Cancer Society explains, it is a medication approved to treat and prevent certain infections caused by parasites or worms, and it was first developed for use in animals — including dogs, cats, horses, and livestock — where it remains a common ingredient in heartworm products.

Mechanism

In susceptible parasites, ivermectin binds to glutamate-gated chloride channels in nerve and muscle cells. The channels stay open, chloride flows in, and the parasite is paralyzed and dies. Mammals have related channels, but they sit behind the blood–brain barrier and are largely protected by a transporter protein (P-glycoprotein), which is the main reason a weight-based human dose can be tolerated while the parasite is not.

Forms used in people

  • Oral tablets (3 mg strength, dosed by body weight) — the form marketed in the US as Stromectol and as generics.
  • Topical lotion for head lice.
  • Topical cream for rosacea; see our separate explainer on using ivermectin cream on the skin for how that differs from the tablets.
  • Veterinary pastes, drenches, injectables, and pour-ons — labeled for animal use only and not approved for human use in any dose.

FDA-approved uses in humans

A clinician's hands reviewing printed clinical trial data tables next to a laptop during an ivermectin evidence review.

The FDA-approved labeling for Stromectol (ivermectin) tablets, published by Merck and on FDA's Drugs@FDA database and NIH's DailyMed, lists two indications: intestinal (nondisseminated) strongyloidiasis caused by the nematode Strongyloides stercoralis, and onchocerciasis caused by Onchocerca volvulus. The labeling notes that the strongyloidiasis indication rests on comparative and open-label studies in which 64–100% of infected patients were cured after a single 200 mcg/kg dose.

Two points about the onchocerciasis indication are easy to miss. The label states that ivermectin is not active against adult Onchocerca worms — it targets the immature microfilariae — so repeat courses are typically needed. And neither approved use covers the broad "parasite cleanse" claims common online.

Form Approved US use Notes
Oral tablets (3 mg) Intestinal strongyloidiasis; onchocerciasis Weight-based single doses; onchocerciasis usually requires retreatment
Topical lotion 0.5% Head lice in patients 6 months and older Single application to dry hair and scalp
Topical cream 1% Inflammatory lesions of rosacea Applied to the face; not interchangeable with tablets
Veterinary products None in humans Labeled for animal use only; not approved for people

Clinicians also prescribe oral ivermectin off-label for several other parasitic conditions — scabies, cutaneous larva migrans, and some lice cases — where guideline bodies and published trials support it even though it is not on the US label. Off-label prescribing is legal and routine; it simply means the manufacturer did not seek FDA review for that indication.

Common off-label discussion and what evidence exists

A single plain white tablet held between fingertips above a glass of water on a kitchen table, illustrating ivermectin side effects.

COVID-19

This is the claim that drove ivermectin into the headlines, and it is the one with the most data. A systematic review and meta-analysis published in Annals of Medicine and Surgery in February 2025 pooled 33 studies with 15,376 participants and found no significant effect of ivermectin on critical outcomes, including mortality (risk ratio 0.911, 95% CI 0.732–1.135) or mechanical ventilation (RR 0.727). A separate 2024 review in the International Journal of Antimicrobial Agents covering 12 randomized controlled trials and 7,035 non-hospitalized patients reported that ivermectin did not reduce hospitalization, all-cause mortality, or adverse events compared with standard of care, placebo, or an active drug. A 2024 multi-centre double-blind randomized trial in BMC Infectious Diseases likewise measured viral load and clinical progression and did not establish benefit.

The FDA's position has not changed: the agency has not approved or authorized ivermectin for the treatment or prevention of COVID-19 in humans, noting that the tablets are approved only at specific doses for certain parasitic worms alongside topical formulations for lice and skin conditions.

Cancer

The American Cancer Society addressed the online claims directly, and the short version is that laboratory and animal signals have not been matched by human trials showing that ivermectin treats cancer. There is no FDA-approved oncology use.

Other claims

Influenza, dengue, "detox," and general immunity are discussed in the same online spaces. For these, high-quality human evidence is either absent or does not support use. Weak evidence is not the same as proof of harm — but it is also not a basis for taking a prescription drug, and a full rundown of what ivermectin does and doesn't do is worth reading before deciding.

Access and cost

Availability shifted quickly. Pharmacy Times reported that four states passed laws allowing over-the-counter-style ivermectin sales, with one pair of measures (SB 19 and Act 464) taking effect June 20, 2025, permitting pharmacists to dispense ivermectin to adults "pursuant to a standing order issued by a health care professional with prescriptive authority." A January 2026 WLBT report noted that as of July 2025 four states — Tennessee, Arkansas, Idaho, and Louisiana — allowed such sales, with additional legislatures filing similar bills. The Texas Tribune reported that Governor Greg Abbott signed a bill making ivermectin available without a prescription in Texas in August 2025, and South Carolina's H. 4042 would bar a required prescription order while directing the Board of Pharmacy to set rules including prohibitions on dispensing when contraindications or clinically significant drug interactions appear in a patient's medication profile.

Practical notes: a state law permitting pharmacist dispensing does not make ivermectin an FDA-approved OTC drug, does not change the approved indications, and does not guarantee any given pharmacy stocks it. Generic tablet pricing varies widely by pharmacy, quantity, and discount program, so check a current price lookup such as GoodRx or ask your pharmacy directly rather than relying on figures quoted online.

Animal products

Veterinary ivermectin — horse paste, cattle pour-on, injectable livestock solutions — is labeled for animal use only and is not approved for human use. Concentrations are built for animals weighing many hundreds of pounds, and inactive ingredients have not been evaluated in people. FDA's own July 2026 emergency use authorization for Ivermectin Liquid for Horses, issued for short-term prevention of New World screwworm infestation, states plainly that the product is not for use in species other than horses.

Side effects

A plastic veterinary paste dosing syringe held in a gloved hand inside a stable, a product labeled for animal use only.

Most people who take a single weight-based oral dose report mild, short-lived effects. Two different patterns show up in the FDA labeling, and the distinction matters.

Drug-related effects

  • Dizziness, drowsiness, headache
  • Nausea, vomiting, diarrhea, abdominal discomfort or loss of appetite
  • Weakness or fatigue, tremor
  • Rash, itching, hives
  • Mild, transient changes in liver enzymes or blood counts (eosinophilia)

Reactions to dying parasites

The Stromectol labeling attributes many reactions in onchocerciasis to allergic and inflammatory responses to the death of microfilariae — the so-called Mazzotti reaction — rather than to the drug itself. These can include fever, joint and muscle pain, swollen and tender lymph nodes, itching, and eye findings such as conjunctivitis or limbitis.

Rare but serious

The label warns that patients with onchocerciasis who are also heavily infected with Loa loa may rarely develop serious or even fatal encephalopathy, either spontaneously or after an effective microfilaricide. Reported features include neck and back pain, red eye, conjunctival hemorrhage, shortness of breath, incontinence, difficulty standing or walking, confusion, lethargy, stupor, seizures, or coma. Severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, have also been reported rarely. Neurologic symptoms after high or repeated doses — pronounced confusion, unsteadiness, vision changes, or seizures — warrant urgent medical care.

Drug interactions and who should avoid it

Ivermectin is metabolized in the liver mainly by CYP3A4 and is a substrate of the P-glycoprotein transporter. That creates two theoretical concerns: strong CYP3A4 inhibitors may raise blood levels, and drugs or foods that impair P-glycoprotein could allow more of the drug into the central nervous system. Reported or cautioned combinations include anticoagulants such as warfarin (monitor INR), other P-glycoprotein substrates, and sedating medications that may compound dizziness or drowsiness. Give your pharmacist a full list — prescriptions, OTC products, and supplements — before a first dose. South Carolina's pending pharmacy legislation explicitly contemplates screening for contraindications and clinically significant interactions at the counter, which is the practical reason to hand over that list even where no prescription is required.

Groups that need extra caution

  • Pregnancy: human data are limited; ivermectin is generally deferred unless a clinician judges treatment necessary.
  • Breastfeeding: the drug appears in breast milk in low concentrations; discuss timing with a clinician.
  • Children under 15 kg (about 33 lb): safety and dosing are not established for oral tablets.
  • Immunocompromised patients: strongyloidiasis can disseminate and may need specialist management and repeat courses.
  • People with liver disease, prior hypersensitivity to ivermectin, or possible Loa loa exposure (travel or residence in parts of Central and West Africa): pre-treatment evaluation is important.

Frequently asked questions

What is ivermectin used for in humans?

In the United States, oral ivermectin is FDA-approved for intestinal strongyloidiasis and onchocerciasis, and topical forms are approved for head lice and rosacea lesions. Clinicians also prescribe it off-label for scabies and some other parasitic infections.

Is ivermectin safe for humans?

At approved weight-based doses for approved indications, ivermectin has a long track record and most side effects are mild. Safety falls apart at unapproved doses, with veterinary products, or when someone takes it instead of care that is indicated for their actual illness.

Can I buy ivermectin over the counter now?

It depends on your state and the individual pharmacy. Several states — including Tennessee, Arkansas, Idaho, and Louisiana per a January 2026 WLBT report, plus Texas after the bill Governor Abbott signed in August 2025 — allow pharmacist dispensing without an individual prescription, and other legislatures have filed similar bills. These state laws do not change the FDA-approved uses. Rules were checked in late 2026; verify your state's current status.

Does ivermectin work against COVID-19?

The pooled randomized evidence says no meaningful benefit. The 2025 Annals of Medicine and Surgery meta-analysis of 33 studies found no significant effect on mortality or mechanical ventilation, and a 2024 review of 12 trials in non-hospitalized patients found no reduction in hospitalization or death. FDA has not approved or authorized it for COVID-19.

Is horse paste the same drug?

The active molecule is the same, but veterinary ivermectin is labeled for animal use only and is not approved for people. Doses are scaled to animals weighing hundreds of pounds, the excipients are not evaluated for human use, and accurate human dosing from a paste syringe is not realistic.

How long do side effects last?

Mild effects such as headache, nausea, or dizziness typically resolve within a day or two of a single dose. Reactions related to dying parasites may last longer and track the treated infection. Severe neurologic or skin symptoms are a reason to seek care immediately rather than wait them out.

Sources